[Use of antipsychotic drugs in a long-term care institution. Experiences with implementing clinical guidelines]

Tidsskr Nor Laegeforen. 1998 May 30;118(14):2144-7.
[Article in Norwegian]

Abstract

Anti-psychotic drugs (neuroleptics) are useful for treating psychoses. However, non-psychotic patients, particularly patients with a deviant behaviour pattern, are often also treated with anti-psychotic drugs. The drugs may induce serious side-effects and should only be used on strict indications and at the lowest possible dosage. In a nursing home for deaf people with additional handicaps we introduced clinical guidelines for the use of anti-psychotic drugs and recorded their use during a two-year period. We found there was a reduction in the number of patients taking anti-psychotic drugs (from 32/54 to 26/54, p = 0.03), as well as a decrease in dosage per user (from median 2.4 mg to 1.7 mg equivalents of haloperidol, p = 0.05). Both the number of patients who were given depot injections and the number of different anti-psychotic drugs per patient were reduced. We conclude that it is possible to reduce the use of anti-psychotic drugs in institutions where long-term care is provided for disabled people.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Drug Utilization*
  • Female
  • Guidelines as Topic
  • Humans
  • Long-Term Care
  • Male
  • Mental Disorders / drug therapy
  • Middle Aged
  • Norway
  • Nursing Homes
  • Psychotropic Drugs / administration & dosage*
  • Psychotropic Drugs / adverse effects

Substances

  • Psychotropic Drugs